Cargando…

GPR40 agonist ameliorates liver X receptor-induced lipid accumulation in liver by activating AMPK pathway

Hepatic steatosis is strongly linked to insulin resistance and type 2 diabetes. GPR40 is a G protein-coupled receptor mediating free fatty acid-induced insulin secretion and thus plays a beneficial role in the improvement of diabetes. However, the impact of GPR40 agonist on hepatic steatosis still r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Meng, Meng, Xiangyu, Xu, Jie, Huang, Xiuqing, Li, Hongxia, Li, Guoping, Wang, Shu, Man, Yong, Tang, Weiqing, Li, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848522/ https://www.ncbi.nlm.nih.gov/pubmed/27121981 http://dx.doi.org/10.1038/srep25237

Ejemplares similares

Empagliflozin activates Sestrin2-mediated AMPK/mTOR pathway and ameliorates lipid accumulation in obesity-related nonalcoholic fatty liver disease
por: Ma, Yuting, et al.
Publicado: (2022)

Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways
por: Li, Chun-Xiao, et al.
Publicado: (2019)

AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model
por: Hu, Liangshuo, et al.
Publicado: (2019)

β-Hydroxybutyrate Suppresses Lipid Accumulation in Aged Liver through GPR109A-mediated Signaling
por: Lee, A Kyoung, et al.
Publicado: (2020)

Identification of Crocetin as a Dual Agonist of GPR40 and GPR120 Responsible for the Antidiabetic Effect of Saffron
por: Zhao, Xiaodi, et al.
Publicado: (2023)

GPR120 Agonist GW9508 Ameliorated Cellular Senescence Induced by ox-LDL
por: Liu, Ruijie, et al.
Publicado: (2020)

LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway
por: Chen, Xue-Yang, et al.
Publicado: (2019)

Crude triterpenoid saponins from Ilex latifolia (Da Ye Dong Qing) ameliorate lipid accumulation by inhibiting SREBP expression via activation of AMPK in a non-alcoholic fatty liver disease model
por: Feng, Rui-Bing, et al.
Publicado: (2015)

Dendrobium officinale Regulates Fatty Acid Metabolism to Ameliorate Liver Lipid Accumulation in NAFLD Mice
por: Lei, Shan-Shan, et al.
Publicado: (2021)

Predicting GPR40 Agonists with A Deep Learning‐Based Ensemble Model
por: Yang, Jiamin, et al.
Publicado: (2023)

GPR40 partial agonists and AgoPAMs: Differentiating effects on glucose and hormonal secretions in the rodent
por: Pachanski, Michele J., et al.
Publicado: (2017)

Rhinacanthin C Ameliorates Insulin Resistance and Lipid Accumulation in NAFLD Mice via the AMPK/SIRT1 and SREBP-1c/FAS/ACC Signaling Pathways
por: Gong, Zhiqiang, et al.
Publicado: (2023)

The Liver X Receptor Agonist TO901317 Ameliorates Behavioral Deficits in Two Mouse Models of Autism
por: Cai, Yulong, et al.
Publicado: (2019)

G Protein-Coupled Receptor GPR35 Suppresses Lipid Accumulation in Hepatocytes
por: Lin, Li-Chiung, et al.
Publicado: (2021)

Icaritin Attenuates Lipid Accumulation by Increasing Energy Expenditure and Autophagy Regulated by Phosphorylating AMPK
por: Wu, Yue, et al.
Publicado: (2021)

Fasiglifam (TAK-875), a G Protein-Coupled Receptor 40 (GPR40) Agonist, May Induce Hepatotoxicity through Reactive Oxygen Species Generation in a GPR40-Dependent Manner
por: Kim, MinJeong, et al.
Publicado: (2018)

Evaluation of the hepatotoxicity of the novel GPR40 (FFAR1) agonist CPL207280 in the rat and monkey
por: Bazydlo-Guzenda, Katarzyna, et al.
Publicado: (2021)

miR-1/AMPK-Mediated Glucose and Lipid Metabolism under Chronic Hypothermia in the Liver of Freshwater Drum, Aplodinotus grunniens
por: Chen, Jianxiang, et al.
Publicado: (2022)

Ginseng Gintonin Contains Ligands for GPR40 and GPR55
por: Cho, Yeon-Jin, et al.
Publicado: (2020)

Genistein alleviates chronic heat stress-induced lipid metabolism disorder and mitochondrial energetic dysfunction by activating the GPR30-AMPK-PGC-1α signaling pathways in the livers of broiler chickens
por: Li, Longlong, et al.
Publicado: (2023)

Asprosin contributes to nonalcoholic fatty liver disease through regulating lipid accumulation and inflammatory response via AMPK signaling
por: Zhang, Bo, et al.
Publicado: (2023)

Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation
por: Hai, Yang, et al.
Publicado: (2023)

T40. GPR52 AGONISTS REPRESENT A NOVEL APPROACH TO TREAT UNMET MEDICAL NEED IN SCHIZOPHRENIA
por: Grottick, Andrew J, et al.
Publicado: (2018)

Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway
por: Li, Qian, et al.
Publicado: (2022)

Honokiol acts as an AMPK complex agonist therapeutic in non-alcoholic fatty liver disease and metabolic syndrome
por: Tian, Ruifeng, et al.
Publicado: (2023)

A Potent Class of GPR40 Full Agonists Engages the EnteroInsular Axis to Promote Glucose Control in Rodents
por: Luo, Jian, et al.
Publicado: (2012)

Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation
por: Zhou, Jingxuan, et al.
Publicado: (2022)

AMG 837: A Novel GPR40/FFA1 Agonist that Enhances Insulin Secretion and Lowers Glucose Levels in Rodents
por: Lin, Daniel C.-H., et al.
Publicado: (2011)

Recombinant Adiponectin Ameliorates Liver Ischemia Reperfusion Injury via Activating the AMPK/eNOS Pathway
por: Zhang, Chuanzhao, et al.
Publicado: (2013)

The GPR120 Agonist TUG-891 Inhibits the Motility and Phagocytosis of Mouse Alveolar Macrophages
por: Su, Xing-Li, et al.
Publicado: (2020)

Isoquercetin Improves Hepatic Lipid Accumulation by Activating AMPK Pathway and Suppressing TGF-β Signaling on an HFD-Induced Nonalcoholic Fatty Liver Disease Rat Model
por: Qin, Guohong, et al.
Publicado: (2018)

AMPK-PPARγ-Cidec Axis Drives the Fasting-Induced Lipid Droplet Aggregation in the Liver of Obese Mice
por: Li, Hongqiang, et al.
Publicado: (2022)

GPR109A activation and aging liver
por: Jadeja, Ravirajsinh N., et al.
Publicado: (2019)

Galanin ameliorates liver inflammation and fibrosis in mice by activating AMPK/ACC signaling and modifying macrophage inflammatory phenotype
por: He, Lingnan, et al.
Publicado: (2023)

Oral Administration of Recombinant Lactoferrin-Expressing Probiotics Ameliorates Diet-Induced Lipid Accumulation and Inflammation in Non-Alcoholic Fatty Liver Disease in Mice
por: Liu, Zhen-Shu, et al.
Publicado: (2022)

Effects of Flutriafol Fungicide on the Lipid Accumulation in Human Liver Cells and Rat Liver
por: Kwon, Hyuk-Cheol, et al.
Publicado: (2021)

Metabolic Syndrome Ameliorated by 4-Methylesculetin by Reducing Hepatic Lipid Accumulation
por: Li, Linghuan, et al.
Publicado: (2022)

Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR
por: Chen, Ping, et al.
Publicado: (2021)

GPR40 modulates epileptic seizure and NMDA receptor function
por: Yang, Yong, et al.
Publicado: (2018)

GPR40: Good Cop, Bad Cop?
por: Alquier, Thierry, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_enu7acirn95ijac4q9nin14rcs